NO20030411L - Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom - Google Patents

Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom

Info

Publication number
NO20030411L
NO20030411L NO20030411A NO20030411A NO20030411L NO 20030411 L NO20030411 L NO 20030411L NO 20030411 A NO20030411 A NO 20030411A NO 20030411 A NO20030411 A NO 20030411A NO 20030411 L NO20030411 L NO 20030411L
Authority
NO
Norway
Prior art keywords
behcet
painful
syndrome
inflammatory
treatment
Prior art date
Application number
NO20030411A
Other languages
English (en)
Other versions
NO20030411D0 (no
NO329574B1 (no
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of NO20030411L publication Critical patent/NO20030411L/no
Publication of NO20030411D0 publication Critical patent/NO20030411D0/no
Publication of NO329574B1 publication Critical patent/NO329574B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Farmasøytiske sammensetninger omfattende som aktive ingredienser effektive doser av hyaluronsyre, glycyrrhetinsyre og polyvinylpyrrolidon, for behandlingen av smertefulle, inflammatoriske og ulcerøse tilstander i fuktige epiteloverflater slik som mukositt og Behcets syndrom.
NO20030411A 2000-07-28 2003-01-27 Farmasøytiske sammensetninger for behandlingen av smertefulle inflammatoriske og ulcerøse tilstander av fuktige epiteloverflater slik som mukositt, stomatitt og Behcets syndrom NO329574B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
PCT/EP2001/008303 WO2002009637A2 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Publications (3)

Publication Number Publication Date
NO20030411L true NO20030411L (no) 2003-01-27
NO20030411D0 NO20030411D0 (no) 2003-01-27
NO329574B1 NO329574B1 (no) 2010-11-15

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030411A NO329574B1 (no) 2000-07-28 2003-01-27 Farmasøytiske sammensetninger for behandlingen av smertefulle inflammatoriske og ulcerøse tilstander av fuktige epiteloverflater slik som mukositt, stomatitt og Behcets syndrom

Country Status (26)

Country Link
US (1) US20020173485A1 (no)
EP (1) EP1313489B1 (no)
JP (1) JP2004505028A (no)
KR (1) KR100761051B1 (no)
CN (1) CN1198625C (no)
AR (1) AR030068A1 (no)
AT (1) ATE289512T1 (no)
AU (2) AU1211302A (no)
BR (1) BRPI0112962B8 (no)
CA (1) CA2424346C (no)
CZ (1) CZ301461B6 (no)
DE (1) DE60109044T2 (no)
ES (1) ES2236324T3 (no)
HK (1) HK1059215A1 (no)
HR (1) HRP20030046B1 (no)
IT (1) IT1318649B1 (no)
MX (1) MXPA03000712A (no)
MY (1) MY130477A (no)
NO (1) NO329574B1 (no)
NZ (1) NZ523832A (no)
PL (1) PL204397B1 (no)
PT (1) PT1313489E (no)
RU (1) RU2272636C2 (no)
UA (1) UA79075C2 (no)
WO (1) WO2002009637A2 (no)
ZA (1) ZA200300712B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997478B1 (en) 2001-02-15 2013-09-04 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20050142208A1 (en) 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
WO2004064850A1 (en) * 2003-01-23 2004-08-05 Ml Laboratories Plc Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
CA2537080A1 (en) * 2003-08-21 2005-03-31 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8377468B2 (en) 2006-08-28 2013-02-19 Rexaderm, Inc. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
EP3574914B1 (en) 2007-11-13 2021-12-29 ViroPharma Biologics LLC Corticosteroid compositions
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
PL2435021T3 (pl) * 2009-05-25 2014-03-31 Sofar Swiss Sa Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach
RU2587570C2 (ru) 2010-04-14 2016-06-20 Алтрия Клаинт Сервисиз Инк. Отформованный бездымный табачный продукт
RU2552936C2 (ru) 2010-11-12 2015-06-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и получения
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
RU2693384C2 (ru) 2013-10-16 2019-07-02 Квест Продактс, ЛЛС Лечение повреждений слизистой оболочки с использованием гиалуронана, доставляемого из приклеивающейся пастилки
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
EP3492073B1 (en) * 2016-07-27 2022-04-27 Ritapharma, Co., Ltd. Oral mucosa application material and method for producing same
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368A1 (en) * 2017-09-20 2019-03-27 Geophyt S.r.L. Food integrator for antineoplastic therapies
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
EP4048237B1 (en) * 2019-10-25 2024-02-28 Mucocort AB Treatment of inflammatory condition in mucous membrane or skin with low amounts of propylene glycol
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
GB2092442B (en) 1981-02-06 1984-02-08 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Also Published As

Publication number Publication date
ITMI20001732A0 (it) 2000-07-28
JP2004505028A (ja) 2004-02-19
CA2424346A1 (en) 2002-02-07
BR0112962A (pt) 2003-06-24
AU2002212113B2 (en) 2006-01-12
RU2272636C2 (ru) 2006-03-27
EP1313489A2 (en) 2003-05-28
HK1059215A1 (en) 2004-06-25
PL362921A1 (en) 2004-11-02
HRP20030046A2 (en) 2004-04-30
HRP20030046B1 (en) 2011-08-31
UA79075C2 (uk) 2007-05-25
DE60109044D1 (de) 2005-03-31
ZA200300712B (en) 2004-02-09
CN1474700A (zh) 2004-02-11
AR030068A1 (es) 2003-08-13
ES2236324T3 (es) 2005-07-16
KR100761051B1 (ko) 2007-10-04
IT1318649B1 (it) 2003-08-27
US20020173485A1 (en) 2002-11-21
NO20030411D0 (no) 2003-01-27
NZ523832A (en) 2003-09-26
DE60109044T2 (de) 2005-07-21
NO329574B1 (no) 2010-11-15
MY130477A (en) 2007-06-29
EP1313489B1 (en) 2005-02-23
ITMI20001732A1 (it) 2002-01-28
PT1313489E (pt) 2005-05-31
AU1211302A (en) 2002-02-13
BR0112962B1 (pt) 2013-12-31
CN1198625C (zh) 2005-04-27
MXPA03000712A (es) 2004-11-01
PL204397B1 (pl) 2010-01-29
ATE289512T1 (de) 2005-03-15
CZ301461B6 (cs) 2010-03-10
WO2002009637A2 (en) 2002-02-07
BRPI0112962B8 (pt) 2021-05-25
WO2002009637A3 (en) 2002-12-05
CA2424346C (en) 2010-03-09
KR20030069979A (ko) 2003-08-27

Similar Documents

Publication Publication Date Title
NO20030411L (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
DK0841899T3 (da) Præparater til topisk indgivelse af aktive bestanddele
HUP0002490A2 (hu) Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben
DK1167354T3 (da) Racemisk huperzin A
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
HUP0301506A2 (hu) Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
SE0001916D0 (sv) Novel formulation
FI932654A (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
ATE241640T1 (de) Fusidinsäure-derivate
JO2370B1 (en) Pharmaceutical formulations for the treatment of painful, inflamed and ulcerated conditions of wet epithelial surfaces such as mucositis, stomatitis and Behçet syndrome
BR0009778A (pt) Composições antifúngicas de pseudomicina e métodos para utilização das mesmas
PT1448219E (pt) Agente antiglaucomatoso e sua utilizacao
ATE299020T1 (de) Verwendung von thiamphenicol in der behandlung von infektionen verursacht durch chlamydia pneumoniae
ATE259802T1 (de) Verbindungen mit antithrombotischer wirkung
FR2832925B1 (fr) Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
HUP0402645A2 (hu) Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ALLIANCE PHARMACEUTICALS LIMITED, GB

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO

MK1K Patent expired